David Waugh,Christopher Self,Guangtao Zhang,Yves Pommier,Robert H. Shoemaker,Michael Currens,John Cardellina,Andrew Jobson,George Lountos,Dominic Scudiero
申请号：
US14353976
公开号：
US20140294767A1
申请日:
2012.10.26
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A method of treating an Hepatitis C Virus infection in a patient, comprising providing a therapeutically effective amount, to a patient in need thereof, of a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein: G1 is a group of the formula or where n is 0, 1, 2, 3, or 4 and Het is a 5- or 6-membered heteroaryl group containing 1 to 4 heteroatoms independently chosen from N, O, and S, which Het is optionally substituted.
